Sodium plays a key role in your body. It helps maintain normal blood pressure, supports the work of your nerves and muscles, and regulates your body’s fluid balance.
MAYO CLINIC
Sodium plays a key role in your body. It helps maintain normal blood pressure, supports the work of your nerves and muscles, and regulates your body’s fluid balance.
MAYO CLINIC
Hyponatremia is a condition that occurs when the level of sodium in your blood is abnormally low. Sodium is an electrolyte, and it helps regulate the amount of water that’s in and around your cells.
In hyponatremia, one or more factors — ranging from an underlying medical condition to drinking too much water during endurance sports causes the sodium in your body to become diluted. When this happens, your body’s water levels rise, and your cells begin to swell. This swelling can cause many health problems, from mild to life-threatening.
Hyponatremia treatment is aimed at resolving the underlying condition. Depending on the cause of hyponatremia, you may simply need to cut back on how much you drink. In other cases of hyponatremia, you may need intravenous fluids and medications.
Sodium we know what systems it effects from yesterday’s article on sodium in general of how it works in the human body. If you don’t know and didn’t get a chance to read it yesterday stop this article going to yesterday’s to read over the general information of how sodium works and effects the human body. This will help you understand the signs and symptoms easier.
Hyponatremia signs and symptoms may include:
Heart disease is the leading cause of death in the United States for both men and women.
Robert F. Malacoff, M.D (is a Board-certified Cardiologist and Electrophysiologist who treats patients at Orange Regional Medical Group and Catskill Regional Medical Group and has been providing exceptional care for more than 35 years)
Many risk factors revolve around the nature of the traumatic event itself.
Traumatic events are more likely to cause PTSD when they involve a severe threat to your life or personal safety: the more extreme and prolonged the threat, the greater the risk of developing PTSD in response. Intentional, human-inflicted harm—such as rape, assault, and torture— also tends to be more traumatic than “acts of God” or more impersonal accidents and disasters. The extent to which the traumatic event was unexpected, uncontrollable, and inescapable also plays a role.
Women’s changing role in our military
A growing number of women are serving in the US military. In 2008, 11 of every 100 Veterans (or 11%) from the Afghanistan and Iraq military operations were women. These numbers are expected to keep rising. In fact, women are the fastest growing group of Veterans.
What stressors do women face in the military?
Here are some stressful things that women might have gone through while deployed:
-Combat Missions. –Military -Sexual Trauma (MST). A number of women (and men) who have served in the military experience MST. MST includes any sexual activity where you are involved against your will, such as insulting sexual comments, unwanted sexual advances, or even sexual assault.
-Feeling Alone. In tough military missions, feeling that you are part of a group is important.
-Worrying About Family. It can be very hard for women with young children or elderly parents to be deployed for long periods of time. Service members are often given little notice. They may have to be away from home for a year or longer. Some women feel like they are “putting their lives on hold.”
Because of these stressors, many women who return from deployment have trouble moving back into civilian life. While in time most will adjust, a small number will go on to have more serious problems like PTSD.
How many women Veterans have PTSD?
Among women Veterans of the conflicts in Iraq and Afghanistan, almost 20 of every 100 (or 20%) have been diagnosed with PTSD. We also know the rates of PTSD in women Vietnam Veterans. An important study found that about 27 of every 100 female Vietnam Veterans (or 27%) suffered from PTSD sometime during their postwar lives. To compare, in men who served in Vietnam, about 31 of every 100 (or 31%) developed PTSD in their lifetime.
What helps? Research shows that high levels of social support after the war were important for those women Veterans.
What can you do to find help?
If you are having a hard time dealing with your wartime memories, there are a number of things that you can do to help yourself. There are also ways you can seek help from others.
Don’t be afraid to ask for help. Most of all, try not to feel bad or embarrassed to ask for help. Asking for help when you need it is a sign of wisdom and strength.
Don’t let PTSD get in the way of your life, hurt your relationships, or cause problems at work or school.
PTSD treatment can help.
Learn what treatment is like to help you make choices about what’s best for you.
If you suspect that you or a loved one has post-traumatic stress disorder (PTSD), it’s important to seek help right away. The sooner PTSD is confronted, the easier it is to overcome. If you’re reluctant to seek help, keep in mind that PTSD is not a sign of weakness, and the only way to overcome it is to confront what happened to you and learn to accept it as a part of your past.
OTHER TYPES OF TREATMENT:
You have to remember the problem is not you, but the traumatic experience you went through whether it was a few weeks ago, a few years ago or 40 years ago. This has left you in a black hole that you can’t get out of. You need to get that bad experience you went through that’s left in your brain under control or with some form of closure. To do that you first need to recognize you need help and you are better off doing it with a group or a counselor. For you to help anyone else you have to help yourself. If you don’t you can’t help anyone or escape from this black hole. Take the step that will help you move on and live a happier life.
“We owe this freedom of choice and action to those men and women in uniform who have served this nation and its interests in time of need. In particular, we are forever indebted to those who have given their lives that we might be free.”
Ronald Reagan (May 26, 1983)
“Health care-associated infections, or HAIs, are infections that people acquire while they are receiving treatment for another condition in a health care setting. HAIs may be caused by any infectious agent, including bacteria, fungi, and viruses, as well as other less common types of pathogens.”
Office of disease prevention and health promotion (http://www.health.gov/hcq/prevent_hai.asp)
THE KEY is to not allowing a Health Acquired Infection-HAI to even occur; this is through PREVENTION!
To reach this key is to understand exactly what a HAI is and how they work in spreading. If you didn’t get a chance to read Tues. Part 1, Wed. Part 2 and Thurs. Part 3 articles do that first to learn what HAIs actually are. The public has to get focused.
Prevention with the most common HAI is UTIs, the CDC recommends healthcare workers to do the following:
Prevention of an infection regarding female as a gender there is nothing you can do about that or the anatomy of the urethra. After having sex there is something you can do in attempting prevention of a UTI. A women can clean the perineal/vaginal area right after the activity to decrease the chance of an infection from occurring through entering her urethra or even or vagina, with thorough drying. Remember water attracts bacteria.
Prevention is key to eliminating central line acquired bloodstream infections in healthcare facilities. The CDC recommends healthcare professionals follow these guidelines to reduce CLABSIs in the workplace:
The key to prevention with surgery sites getting infected is the following:
Prior to Surgery
During Surgery the following takes place:
After Surgery
The public must get involved with medical staff to stay on top of prevention with HAIs. This is to allow HAIs to go on a continual reduction. This will only occur if both staff of a health care facility get involved with the public. Having everyone nationally in all communities take part will only happen if increased health awareness is provided, which in the end will help decrease infection. This will indirectly put a reduction on our medical debt, which will take time. Our medical technology has taken us so far in learning and treating infection compared to 100 years ago and even less; but we need the public to get more focused on how to prevent HAIs as well. We can’t leave it up to the health care facilities staff to only take action to prevent HAIs. The public needs to take part in this now. Broadening the public’s knowledge will help prevent people from getting a HAI when admitted to the hospital or going to any type of medical facility for care. It also will get the public more focused on HAIs allowing the family with the patient to take more action in prevention of HAIs (The key). We the people in our society are responsible in reaching the goal for better health. The medical staff, who is already carrying out infection control measures, with the public’s help through increased knowledge on HAIs will only increase the chance of continued reduction in infections, to possibly minimal infections one day, in all types of hospitals or health care facilities. We all must get focused!
“More action is needed at every level of public health and health care to improve patient safety and eliminate infections that commonly threaten hospital patients.”
CDC (Center for disease control and prevention).
1-C-DIFF or C-difficile, know as Clostridium difficile infection (CDI), or Clostridium difficile–associated disease (CDAD), which is an infection of the intestines caused by the anaerobic, spore-forming, gram-positive bacillus C. difficile. This microbe was first identified in 1935 when it was isolated from the stools of neonates. C. difficile produces heat-resistant spores that can remain viable on fomites in the environment for years, becoming a source of outbreaks in healthcare facilities. This bacillus also produces two types of toxins: Toxin A (an enterotoxin) and Toxin B (a cytotoxin). These toxins are responsible for the inflammatory responses of the colon, which results in loss of epithelial integrity and the production of watery diarrhea. C. difficile is the most common cause of antibiotic-associated diarrhea and pseudomembranous colitis and has proved extremely difficult to control due to new, more resistant strains.
The greatest risk factor for CDI is the use of antibiotics, such as cephlasporins, clindamycin, or the penicillins, because these antibiotics kill the normal flora of the colon, causing overgrowth of C. difficile. Risk is increased for those taking multiple antimicrobials and those who take antimicrobials for longer time periods. Other risk factors for CDI include advanced age. Although almost half of the infections occur in persons younger than 65, most CDI-related deaths occur in the elderly. People with HIV infection, compromised immune systems, and compromised physical status are also at increased risk for CDI. Hospital admission increases one’s chance of acquiring CDI, as does gastrointestinal surgery.
Transmission of CDI occurs by the fecal-oral route.
The time between exposure to C. difficile and infection is 2 to 3 days. Symptoms of CDI vary greatly, ranging from asymptomatic to mild (fever, malaise, and gastrointestinal symptoms, including abdominal pain and cramps, and mild to moderate foul-smelling diarrhea that is rarely bloody) to extremely severe toxic megacolon, septic shock, and even death. Complications of C. difficile include pseudomembranous colitis or fulminant colitis.
Diagnosis is based on clinical history (antibiotic use in the previous 2 months, diarrhea after 72 or more hours of hospitalization), and presence of C. difficile in the stool. Stool culture is the most sensitive test and is often used for diagnosis in the hospital setting. Colonoscopy revealing histopathology with pseudomembranous colitis is also diagnostic but not necessary in most cases.
Treatment for CDI begins with discontinuation of the antibiotic causing the infection. In many cases, this step is the only necessary treatment since normal flora can reestablish in the colon. If mild to moderate diarrhea persists, patients can be treated with either metronidazole or vancomycin. In cases of severe diarrhea, vancomycin is the drug of choice for treatment due to its history of rapid symptom resolution and overall fewer treatment failures. Although antibiotic treatment will clear the infection, it will not kill the bacterial spores. In 27% of cases, relapse occurs within 3 weeks of antibiotic termination. In extreme cases, colectomy with end ileostomy may be necessary. Treatment for asymptomatic cases is not recommended.
An innovative CDI treatment may be on the horizon. Researchers have shown that C. difficile infection arises as the result of the disruption of natural flora in the intestines, a condition known as dysbiosis. New research in the treatment of CDI involves isolating specific gut bacteria in the fecal matter of healthy individuals and incorporating it into the gut of a person with CDI to restore normal flora and cure the infection.
CDI can be catastrophic to patients and indeed to entire healthcare facilities if an outbreak occurs. To prevent CDI, follow these guidelines from the CDC:
2- MRSA Methicillin-resistant Staphylococcus aureus (MRSA), also known as multidrug resistant S. aureus, includes any strain of S. aureus that has become resistant to the group of antibiotics known as beta-lactam antibiotics. Included in this group are the penicillins (methicillin, amoxicillin, oxacillin) and cephalosporins. Staphylococcus aureus includes gram-positive, nonmotile, non-spore-forming cocci that can be found alone, in pairs, or in grapelike clusters.
When penicillin was first introduced in the early 1940s, it was considered to be a wonder drug because it reduced the death rate from Staphylococcus infection from 70% to 25%. Unfortunately, by 1944, drug resistance was beginning to occur, so methicillin was synthesized, and, in 1959, it became the world’s first semisynthetic penicillin. Shortly thereafter in 1961, staphylococcal resistance to methicillin began as well, and the name “methicillin-resistant S. aureus” and the acronym MRSA were coined. Although methicillin was discontinued in 1993, the name and acronym have remained because of MRSA history.
MRSA is now the most common drug-resistant infection acquired in healthcare facilities. In addition to becoming more problematic as a top HAI in recent years, transmission of MRSA has also become more common in children, prison inmates, and sports participants. Community-associated MRSA (CA-MRSA) most often presents in the form of skin infections. Hospital-acquired MRSA (HA-MRSA) infections manifest in various forms, including bloodstream infections, surgical site infections, and pneumonia. Although approximately 25–30% of persons are colonized in the nasal passages with Staphylococcus, less than 2% are colonized with MRSA. MRSA are extremely resistant and can survive for weeks on environmental surfaces. Transfer of the pathogen can occur directly from patient contact with a contaminated surface or indirectly as healthcare workers touch contaminated surfaces with gloves or hands and then touch a patient.
Risk factors for healthcare-acquired MRSA infection include advanced age, young age, use of quinolone antibiotics, and extended stay in a healthcare facility. Those with diabetes, cancer, or a compromised immune system are also at increased risk of infection.
Symptoms of MRSA infection vary depending on the type and stage of infection and the susceptibility of the organism. Skin infections may appear as painful, red, swollen pustules or boils; as cellulitis; or as a spider bite or bump. They can be found in areas where visible skin trauma has occurred or in areas covered by hair. Patients may also have fever, headaches, hypotension, and joint pain. Complications of MRSA-related skin infections include endocarditis, necrotizing fasciitis, osteomyelitis, and sepsis.
Treatment for MRSA infections varies based on site of infection, stage of infection, and age of the individual. Treatment includes drainage of abscesses, surgical debridement, decolonization strategies, and antimicrobial therapy with antibiotics such as vancomycin, clindamycin, daptomycin, linezolid, rifampin, trimethoprim-sulfamethoxazole (TMP-SMX), quinupristin-dalfopristin, telavancin, and tetracyclines (limited use). MRSA is rapidly becoming resistant to rifampin; therefore, this drug should not be used alone in the treatment of MRSA infections. Consultation with an infectious disease specialist is recommended for treatment of severe MRSA infections.
3-VRE- Vancomycin-Resistant Enterococci Infection (VRE) or Enterococci (formerly known as Group D streptococci). VRE are non-spore-forming, gram-positive cocci that exist in either pairs or short chains. They are commonly found in the human intestine or the female genital tract. The most common organism associated with vancomycin-ressistant enterococci (VRE) infection in hospitals is Enterococcus faecium. Enterococcus faecalis is also a cause of human disease. VRE infections can occur in the urinary tract, in wounds associated with catheters, in the bloodstream, and in surgical sites. Enterococci are a common cause of endocarditis, intra-abdominal infections, and pelvic infections.
VRE was first reported in Europe in 1986, followed in 1989 by the first report in the United States. Since then it has spread rapidly. Between 1990 and 1997, the prevalence of VRE in hospital patients increased from less than 1% to 15%.
VRE, which is found predominantly in hospitalized or recently hospitalized patients, are difficult to eliminate because they are able to withstand extreme temperatures, can survive for long periods on environmental surfaces, and are resistant to vancomycin. Transmission of VRE occurs most commonly in the form of person-to-person contact by the hands of healthcare workers after contact with the blood, urine, or feces an infected individual. VRE is also spread from contact with environmental surfaces, or through contact with the open wound of an infected person.
People most at risk for infection with VRE include the elderly and those with diabetes, those with compromised immune systems, and those who are already colonized with the bacteria. Prolonged hospitalization, catheterization (urinary and intravenous), and long-term use of vancomycin or other antibiotics also increase a person’s risk of infection.
Symptoms of VRE infection vary depending on the site of infection and may include erythema, warmth, edema, fever, abdominal pain, pelvic pain, and organ pain. Definitive diagnosis is made by culture and susceptibility testing with specimens obtained from suspected sites of infection.